Tyers Asset Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$309K Hold
3,216
0.01% 608
2019
Q2
$275K Hold
3,216
0.01% 656
2019
Q1
$268K Hold
3,216
0.01% 633
2018
Q4
$206K Hold
3,216
0.01% 669
2018
Q3
$255K Buy
3,216
+784
+32% +$60.6K 0.01% 692
2018
Q2
$178K Hold
2,432
0.01% 717
2018
Q1
$154K Hold
2,432
0.01% 753
2017
Q4
$124K Buy
2,432
+432
+22% +$22.5K ﹤0.01% 810
2017
Q3
$105K Buy
2,000
+320
+19% +$16.1K ﹤0.01% 803
2017
Q2
$86K Buy
1,680
+832
+98% +$41.2K ﹤0.01% 809
2017
Q1
$38K Sell
848
-176
-17% -$7.57K ﹤0.01% 865
2016
Q4
$45K Buy
+1,024
New +$43.5K ﹤0.01% 807

Other funds holding CNMD

Tyers Asset Management's CNMD Position: Q3 2019 in Review

Tyers Asset Management held its CONMED (CNMD) position steady in Q3 2019 at 3,216 shares worth $309K. The position accounts for 0.01% of the portfolio, ranked #608.

Tyers Asset Management first reported a position in CNMD in Q4 2016 and has held it in 12 quarters since. 234 funds tracked by Wall St. Rank hold CNMD as of Q3 2019.

  • Tyers Asset Management held 3,216 shares of CONMED worth $309K as of Q3 2019.
  • Tyers Asset Management left its CONMED share count unchanged in Q3 2019.
  • CONMED made up 0.01% of Tyers Asset Management's portfolio in Q3 2019, its #608 holding.
  • Tyers Asset Management first reported a position in CONMED in Q4 2016 and has held it in 12 quarters since.
  • 234 funds tracked by Wall St. Rank held CONMED as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.